Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1987-08-26
1988-09-27
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540523, A61K 3155, C07D40104, C07D40106, C07D40114, C07D40304, C07D40306, C07D40314, C07D41304, C07D41306, C07D41314, C07D41704, C07D41706, C07D41714
Patent
active
047742399
ABSTRACT:
A new class of benzazepine derivatives having the general formula ##STR1## including pharmaceutically acceptable salts, are disclosed. These compounds are useful as cardiovascular agents, particularly as vasodilators.
REFERENCES:
patent: 3312691 (1987-04-01), Wertner et al.
patent: 3330823 (1967-07-01), Bernstein et al.
patent: 3562257 (1971-02-01), Kugita et al.
patent: 3748321 (1973-07-01), Krapcho
Chemical Abstracts, vol. 106 (1987), Abstracting European Patent Application EP205,334, published Dec. 17, 1986.
Reaction of 3-Phenylglycidic Esters IV.sup.1, Reaction of Methyl 3-(4-Methoxyphenyl)Glycidate With 2-Nitrophenol and Synthesis of 1,5-Benzoxazenine Derivatives, Hashiyama, et al. (Chem. Pharm. Bull.).
Bond Robert T.
E. R. Squibb & Sons Inc.
Furman Jr. Theodore R.
Levinson Lawrence S.
LandOfFree
Benzazepine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzazepine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzazepine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2398097